291 related articles for article (PubMed ID: 35843594)
21. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
[TBL] [Abstract][Full Text] [Related]
22. Photothermal MnO
Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
[TBL] [Abstract][Full Text] [Related]
23. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
[TBL] [Abstract][Full Text] [Related]
24. Folated pH-degradable nanogels for the simultaneous delivery of docetaxel and an IDO1-inhibitor in enhancing cancer chemo-immunotherapy.
Qiao H; Chen X; Chen E; Zhang J; Huang D; Yang D; Ding Y; Qian H; Feijen J; Chen W
Biomater Sci; 2019 Jun; 7(7):2749-2758. PubMed ID: 30997445
[TBL] [Abstract][Full Text] [Related]
25. Detection of indoleamine 2,3-dioxygenase 1-expressing cells in canine normal and tumor tissues.
Ikeda N; Kato D; Tsuboi M; Yoshitake R; Eto S; Yoshimoto S; Shinada M; Kamoto S; Hashimoto Y; Takahashi Y; Chambers J; Uchida K; Nishimura R; Nakagawa T
J Vet Med Sci; 2021 Dec; 83(12):1885-1890. PubMed ID: 34690223
[TBL] [Abstract][Full Text] [Related]
26. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
Zhou L; Zhang P; Wang H; Wang D; Li Y
Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
[TBL] [Abstract][Full Text] [Related]
27. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
28. Cu
He J; Song R; Xiao F; Wang M; Wen L
Int J Nanomedicine; 2023; 18():3021-3033. PubMed ID: 37312933
[TBL] [Abstract][Full Text] [Related]
29. Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway.
Yang X; Zhang W; Jiang W; Kumar A; Zhou S; Cao Z; Zhan S; Yang W; Liu R; Teng Y; Xie J
J Nanobiotechnology; 2021 Jun; 19(1):182. PubMed ID: 34127005
[TBL] [Abstract][Full Text] [Related]
30. Gene silencing of indoleamine 2,3-dioxygenase hinders tumor growth through angiogenesis inhibition.
Pan J; Yuan K; Peng S; Huang Y; Zhang Y; Hu Y; Feng Y; Shi Y; Liu Y; Wang H; Zhou N; Min W
Int J Oncol; 2017 Jun; 50(6):2136-2144. PubMed ID: 28498425
[TBL] [Abstract][Full Text] [Related]
31. Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy.
Choi J; Shim MK; Yang S; Hwang HS; Cho H; Kim J; Yun WS; Moon Y; Kim J; Yoon HY; Kim K
ACS Nano; 2021 Jul; 15(7):12086-12098. PubMed ID: 34165970
[TBL] [Abstract][Full Text] [Related]
32. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
[TBL] [Abstract][Full Text] [Related]
33. LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells.
Kim NS; Torrez T; Langridge W
Cell Immunol; 2019 Apr; 338():32-42. PubMed ID: 30910218
[TBL] [Abstract][Full Text] [Related]
34. Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor.
Song X; Si Q; Qi R; Liu W; Li M; Guo M; Wei L; Yao Z
Front Immunol; 2021; 12():800630. PubMed ID: 35003126
[TBL] [Abstract][Full Text] [Related]
35. Charge and Size Dual Switchable Nanocage for Novel Triple-Interlocked Combination Therapy Pattern.
Yang R; Zhang Z; Fu S; Hou T; Mu W; Liang S; Gao T; Guan L; Fang Y; Liu Y; Zhang N
Adv Sci (Weinh); 2020 Sep; 7(18):2000906. PubMed ID: 32999836
[TBL] [Abstract][Full Text] [Related]
36. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
[TBL] [Abstract][Full Text] [Related]
37. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
[TBL] [Abstract][Full Text] [Related]
38. Dual-responsive PEG-lipid polyester nanoparticles for siRNA and vaccine delivery elicit anti-cancer immune responses by modulating tumor microenvironment.
Liu Z; Zhao L; Feng Y; Wang Q; Dong N; Zhang Y; Yin T; He H; Tang X; Gou J; Yang L
Biomater Sci; 2023 Sep; 11(19):6619-6634. PubMed ID: 37608695
[TBL] [Abstract][Full Text] [Related]
39. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8
Dey S; Sutanto-Ward E; Kopp KL; DuHadaway J; Mondal A; Ghaban D; Lecoq I; Zocca MB; Merlo LMF; Mandik-Nayak L; Andersen MH; Pedersen AW; Muller AJ
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690770
[TBL] [Abstract][Full Text] [Related]
40. Self-Delivery Photodynamic Re-educator Enhanced Tumor Treatment by Inducing Immunogenic Cell Death and Improving Immunosuppressive Microenvironments.
Kong RJ; Li YM; Huang JQ; Yan N; Wu YY; Cheng H
ACS Appl Mater Interfaces; 2023 Dec; 15(51):59165-59174. PubMed ID: 38100370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
